NPPA notified regarding the fixation of Bictegravir sodium eq. to Bictegravir 50 mg + Emtricitabine IP 200 mg + Tenofovir Alafenamide Fumarate eq. to Tenofovir Alafenamide 25 mg

Jan 08, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00

Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on January 08, 2025, notified regarding the fixation of the retail price of Bictegravir sodium eq. to Bictegravir 50 mg + Emtricitabine IP 200 mg + Tenofovir Alafenamide Fumarate eq. to Tenofovir Alafenamide 25 mg.

It has fixed the rate at Rs. 132.58/- for each film-coated tablet containing: Bictegravir sodium eq. to Bictegravir 50 mg + Emtricitabine IP 200 mg + Tenofovir Alafenamide Fumarate eq. to Tenofovir Alafenamide 25 mg.

[Notification no. - 19(4348)/2024/DP/NPPA/DIV.II]

View Document 1

Bookmark

Related Updates

View More Related Updates


Alternate Text

Get updates on the go on RegUpdate Mobile App.

Alternate Text
✦ NEW  ·  AI ASSISTANT